Joshua J Skydel

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Systemic Lupus Erythematosus

Drug Administration

Top Venues

The Journal of rheumatology

Clinical trials (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology 51 (3) (2024)
Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology 51 (3) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology 51 (3) (2024)
Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology 51 (3) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology (2023)
Joshua J Skydel, Audrey D Zhang, Sanket S Dhruva, Joseph R Ross, Joshua D Wallach
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018. Clinical trials (London, England) 18 (4) (2021)
Mallory K Ellingson, Xiaoting Shi, Joshua J Skydel, Kate Nyhan, Richard Lehman, Joseph S Ross, Joshua D Wallach
Publishing at any cost: a cross-sectional study of the amount that medical researchers spend on open access publishing each year. BMJ open 11 (2) (2021)